Pyxis Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.92
|
0.00
|
0.92
|
100.00%
|
|
2022-12-31
|
-0.93
|
0.00
|
0.93
|
100.00%
|
|
2022-09-30
|
-0.81
|
-0.85
|
-0.04
|
-4.94%
|
|
2022-06-30
|
-0.76
|
-0.79
|
-0.03
|
-3.95%
|
|
2022-03-31
|
-0.61
|
-0.97
|
-0.36
|
-59.02%
|
|
2021-12-31
|
-0.36
|
-1.98
|
-1.62
|
-450.00%
|
|
2021-09-30
|
-0.51
|
-8.96
|
-8.45
|
-1656.86%
|
|
2021-06-30
|
0.00
|
-1.02
|
-1.02
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.61
|
|
2021-12-31
|
-27.89
|
|
2020-12-31
|
-18.67
|
|
2019-12-31
|
-2.74
|